FdaApplication

ANDA 218109

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSOMERSET THERAPEUTICS LLC
application_typeANDA
approval_date2024-09-09

Products (1)

ProductActive ingredientStrengthDosage form
CABERGOLINECABERGOLINE0.5MGTABLET;ORAL

1 product